Ikena Oncology Inc. (IKNA)
NASDAQ: IKNA
· Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM
Ikena Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M | -19.49M | -17.34M | -17.11M | -14.22M | -14.1M | -17.34M | -20.49M | -16.84M | 2.8M | -14.52M | -12.68M | -9.72M |
Depreciation & Amortization | 87K | 87K | 89K | 90K | 92K | 219K | 305K | 242K | 242K | 231K | 210K | 213K | 148K | 180K | 163K | -421K | 713K | 89K |
Stock-Based Compensation | 458K | 904K | 998K | 1.02M | 1.28M | 2M | 1.75M | 2M | 1.88M | 2M | 1.86M | 1.81M | 1.96M | 1.9M | 1.58M | 1.45M | 1.26M | 885K |
Other Working Capital | n/a | -3.18M | 2.18M | -196K | 320K | -5.11M | -4.5M | -4.12M | -1.91M | -8.27M | -4.58M | -1.12M | -3.48M | -5.38M | -20.22M | -4.83M | -5.15M | -3.47M |
Other Non-Cash Items | -1.2M | 337K | 240K | 253K | 2M | 3.49M | 6.24M | 471K | 344K | -193K | 277K | 371K | 516K | 354K | 306K | 868K | -273K | 273K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.25M | -577K | -597K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -3.27M | 1.54M | -64K | -181K | -5.27M | -6.38M | -4.79M | -2.9M | -7.6M | -5.9M | -2.28M | -1.58M | -5.38M | -18.21M | -5.37M | -4.75M | -4.7M |
Operating Cash Flow | -3.42M | -10.56M | -6.26M | -8.94M | -12.5M | -18.3M | -21.82M | -20M | -18.14M | -19.78M | -17.66M | -17.22M | -19.45M | -19.78M | -13.37M | -17.99M | -15.72M | -13.17M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -262K | n/a | -4K | -152K | -231K | -1.13M | -36K | -33K | -550K | -184K | -187K | -839K |
Cash Acquisitions | n/a | n/a | n/a | -245K | 185K | 60K | -4K | n/a | 4K | n/a | -10.73M | -36.91M | -20.52M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6M | -17.19M | -7.26M | -8.77M | -9.97M | -62.3M | -24.84M | -18.17M | -5.32M | -41.73M | -26.48M | -14.87M | -8.98M | -166.02M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 45.95M | 25.12M | 15.22M | 18.04M | 13.7M | 13.5M | 45.48M | 50.06M | 28M | 31.07M | 37.2M | 51.78M | 29.5M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -15M | n/a | -7.5M | 435K | 185K | -48.74M | 20.64M | 31.89M | 4K | n/a | 10.73M | 36.91M | 20.52M | -166.02M | -1.77M | n/a | n/a | n/a |
Investing Cash Flow | 24.95M | 7.93M | 463K | 9.45M | 3.92M | -48.74M | 20.38M | 31.89M | 22.68M | -10.81M | 10.5M | 35.78M | 20.49M | -166.05M | -550K | -184K | -187K | -839K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 108K | -108K | -663K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.09M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 60K | 39.03M | 37M | n/a | 1K | 24K | 575K | 495K | 236K | 69K | 35K | 96K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 60K | 38.92M | 37M | n/a | 1K | 24K | 575K | 495K | 236K | 69K | -1.09M | 132.53M |
Net Cash Flow | 21.53M | -2.63M | -5.8M | 516K | -8.58M | -67.04M | -1.38M | 50.81M | 41.54M | -30.59M | -7.16M | 18.59M | 1.61M | -185.34M | -13.68M | -18.11M | -17.01M | 118.52M |
Free Cash Flow | -3.42M | -10.56M | -6.26M | -8.94M | -12.5M | -18.3M | -22.08M | -20M | -18.15M | -19.94M | -17.89M | -18.35M | -19.49M | -19.82M | -13.92M | -18.17M | -15.91M | -14.01M |